BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36710405)

  • 1. Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in France.
    Atsou KM; Rachet B; Cornet E; Chretien ML; Rossi C; Remontet L; Roche L; Giorgi R; Gauthier S; Girard S; Böckle J; Wasse SK; Rachou H; Bouzid L; Poncet JM; Orazio S; Monnereau A; Troussard X; Mounier M; Maynadie M
    Cancer Med; 2023 Apr; 12(7):8911-8923. PubMed ID: 36710405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.
    Kinoshita A; Miyachi H; Matsushita H; Yabe M; Taki T; Watanabe T; Saito AM; Tomizawa D; Taga T; Takahashi H; Matsuo H; Kodama K; Ohki K; Hayashi Y; Tawa A; Horibe K; Adachi S
    Br J Haematol; 2014 Oct; 167(1):80-6. PubMed ID: 25039450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The applicability of the WHO classification in paediatric AML. A NOPHO-AML study.
    Sandahl JD; Kjeldsen E; Abrahamsson J; Ha SY; Heldrup J; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Forestier E; Hasle H
    Br J Haematol; 2015 Jun; 169(6):859-67. PubMed ID: 25819835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
    Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.
    Gangatharan SA; Grove CS; P'ng S; O'Reilly J; Joske D; Leahy MF; Threlfall T; Wright MP
    Intern Med J; 2013 Aug; 43(8):903-11. PubMed ID: 23611681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients.
    Xu XQ; Wang JM; Gao L; Qiu HY; Chen L; Jia L; Hu XX; Yang JM; Ni X; Chen J; Lü SQ; Zhang WP; Song XM
    Am J Hematol; 2014 Sep; 89(9):874-81. PubMed ID: 24861848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification.
    Qiu S; Jiang E; Wei H; Lin D; Zhang G; Wei S; Zhou C; Liu K; Wang Y; Liu B; Liu Y; Gong B; Gong X; Feng S; Mi Y; Han M; Wang J
    BMC Cancer; 2017 Aug; 17(1):534. PubMed ID: 28793875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics in the management of acute myeloid leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Luquet I; Bidet A; Cuccuini W; Lafage-Pochitaloff M; Mozziconacci MJ; Terré C
    Ann Biol Clin (Paris); 2016 Oct; 74(5):535-546. PubMed ID: 27545007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
    Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.
    Lazzarotto D; Candoni A; Nadali G; Pavan L; Lessi F; Mosna F; Simeone E; Ventura G; Gherlinzoni F; Semenzato G; Pizzolo G; Fanin R
    Eur J Haematol; 2016 Jun; 96(6):586-92. PubMed ID: 26186084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group.
    Chanswangphuwana C; Polprasert C; Owattanapanich W; Kungwankiattichai S; Tantiworawit A; Rattanathammethee T; Limvorapitak W; Saengboon S; Niparuck P; Puavilai T; Julamanee J; Saelue P; Wanitpongpun C; Nakhakes C; Prayongratana K; Sriswasdi C
    Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):e1075-e1083. PubMed ID: 36117042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC).
    Miesner M; Haferlach C; Bacher U; Weiss T; Macijewski K; Kohlmann A; Klein HU; Dugas M; Kern W; Schnittger S; Haferlach T
    Blood; 2010 Oct; 116(15):2742-51. PubMed ID: 20581309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.
    Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB;
    Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics.
    Mayer J; Arthur C; Delaunay J; Mazur G; Thomas XG; Wierzbowska A; Ravandi F; Berrak E; Jones M; Li Y; Kantarjian HM
    BMC Cancer; 2014 Feb; 14():69. PubMed ID: 24498872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Myeloid Leukemia (AML) In Elderly: Cytogenetic Characteristics of Patients Treated At Hematology and Pediatric Oncology Center in Casablanca.
    Bendari M; Khoubila N; Cherkaoui S; Hada N; Lamchahab M; Oukache B; Madani A; Rachid M; Qachouh M; Quessar A
    Open Access Maced J Med Sci; 2018 Dec; 6(12):2328-2332. PubMed ID: 30607185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia].
    Ma L; Zhao T; Chen YY; Jiang H; Xu LP; Zhang XH; Wang Y; Sun YQ; Mo XD; Huang XJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):124-131. PubMed ID: 36948866
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality.
    Sorror ML; Storer BE; Fathi AT; Gerds AT; Medeiros BC; Shami P; Brunner AM; Sekeres MA; Mukherjee S; Peña E; Elsawy M; Wardyn S; Whitten J; Moore R; Becker PS; McCune JS; Appelbaum FR; Estey EH
    JAMA Oncol; 2017 Dec; 3(12):1675-1682. PubMed ID: 28880971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic Abnormalities In Acute Myeloid Leukaemia Patients.
    Shaikh MR; Haider G; Memon P; Rahool R; Nouman M; Beg S; Meher K; Zahoor S; Sami A; Pavan B
    J Ayub Med Coll Abbottabad; 2020; 32(1):33-37. PubMed ID: 32468751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.